Scott Askin is currently a Portfolio Innovation Director with Novartis, based in their head office in Basel Switzerland, and brings with him over 20 years of Pharma industry experience.
In roles focusing on Data Management, Data Standards, Regulatory Affairs and Digital Innovation, Scott has led several of Novartis’s innovation projects and advises program teams internally in areas such as eConsent, eSource, Decentralized Clinical Trials, Blockchain & AI, and also collaborates externally in cross-industry initiatives.

Scott Askin has a Bachelor’s in Computing & Management Sciences, a Masters in Regulatory Affairs and Health Policy and is a published author in both regulatory and digital innovation.